The impact of C‐reactive protein‐albumin‐lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy

AIM: The C‐reactive protein (CRP)‐albumin‐lymphocyte (CALLY) index is a novel inflammation‐based biomarker, which has been associated with long‐term outcomes in patients with hepatocellular carcinoma. We aimed to investigate whether the CALLY index can predict the prognosis for distal cholangiocarci...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsunematsu, Masashi, Haruki, Koichiro, Taniai, Tomohiko, Tanji, Yoshiaki, Shirai, Yoshihiro, Furukawa, Kenei, Uwagawa, Tadashi, Onda, Shinji, Yanagaki, Mitsuru, Usuba, Teruyuki, Nakabayashi, Yukio, Okamoto, Tomoyoshi, Ikegami, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154875/
https://www.ncbi.nlm.nih.gov/pubmed/37152771
http://dx.doi.org/10.1002/ags3.12637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154875/
https://www.ncbi.nlm.nih.gov/pubmed/37152771
http://dx.doi.org/10.1002/ags3.12637

Ejemplares similares